Molndal, Sweden

Bengt Magnus Lindstedt

This inventor holds 2 USPTO granted patents. Top assignee: Astra Aktiebolag. Active years: 1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bengt Magnus Lindstedt. Retrieved from https://idiyas.com/inventor/bengt-magnus-lindstedt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1998

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Bengt Magnus Lindstedt

Introduction

Bengt Magnus Lindstedt is a notable inventor based in Molndal, Sweden. He has made significant contributions to the field of pharmaceutical formulations. With a total of 2 patents to his name, Lindstedt's work focuses on the development of innovative drug delivery systems.

Latest Patents

Lindstedt's latest patents include groundbreaking formulations that contain pharmacologically active substances. One of his patents describes a preparation of a pharmacologically active ionizable substance, wherein the active substance is ionically complexed to an ion-exchanger resin. This resin is embedded in a hydrophilic eroding matrix, along with a process for its manufacture. His work aims to enhance the efficacy and delivery of pharmaceutical compounds.

Career Highlights

Lindstedt is associated with Astra Aktiebolag, a leading company in the pharmaceutical industry. His role at Astra has allowed him to contribute to the advancement of drug formulations and delivery systems. His innovative approaches have garnered attention in the scientific community.

Collaborations

Lindstedt has collaborated with Per Johan Lundberg, a fellow professional in the field. Their partnership has likely fostered the development of new ideas and innovations in pharmaceutical research.

Conclusion

Bengt Magnus Lindstedt's contributions to pharmaceutical formulations demonstrate his commitment to innovation in the field. His patents reflect a deep understanding of drug delivery systems, which can significantly impact patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…